45. Walfisch A, Koren G. The “warfarin window” in pregnancy: the importance of
half-life. J Obstet Gynaecol Can 2010;32:988–9.
46. Bates SM, Ginsberg JS. Anticoagulants in pregnancy: fetal effects. Baillières
Clin Obstet Gynaecol 1997;11:479–88.
47. Stevenson RE, Burton OM, Ferlauto GJ, Taylor HA. Hazards of oral anticoagulants during pregnancy. JAMA 1980;243:1549–51.
48. Ginsberg JS, Hirsh J. Anticoagulants during pregnancy. Annu Rev Med
49. Wong V, Cheng CH, Chan KC. Fetal and neonatal outcome of exposure to
anticoagulants during pregnancy. Am J Med Genet 1993;45: 17–21.
50. Blickstein D, Blickstein I. The risk of fetal loss associated with Warfarin anticoagulation. Int J Gynaecol Obstet 2002;78:221–5.
51. Burnett AE, Mahan CE, Vazquez SR, et al. Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment. J Thromb
52. Bapat P, Pinto LSR, Lubetsky A, et al. Examining the transplacental passage
of apixaban using the dually perfused human placenta. J Thromb Haemost
53. Bapat P, Pinto LSR, Lubetsky A, et al. Rivaroxaban transfer across the dually perfused isolated human placental cotyledon. Am J Obstet Gynecol
54. Bapat P, Kedar R, Lubetsky A, et al. Transfer of dabigatran and dabigatran
etexilate mesylate across the dually perfused human placenta. Obstet Gynecol
55. Savaysa [package insert]. Parsippany (NJ): Daiichi Sankyo, Inc; 2015.
56. Filipecki S, Tomkowski W, Hajduk B, et al. [Outcome of patients with clinically
acute massive pulmonary embolism]. Pneumonol Alergol Pol 1994;62:132–7.
57. Holden EL, Ranu H, Sheth A, et al. Thrombolysis for massive pulmonary
embolism in pregnancy--a report of three cases and follow up over a two year
period. Thromb Res 2011;127:58–9.
58. te Raa GD, Ribbert LS, Snijder RJ, Biesma DH. Treatment options in massive
pulmonary embolism during pregnancy; a case-report and review of literature.
Thromb Res 2009;124: 1–5.
59. Leonhardt G, Gaul C, Nietsch HH, et al. Thrombolytic therapy in pregnancy.
J Thromb Thrombolysis 2006;21:271–6.
60. Colombier S, Niclauss L. Successful surgical pulmonary embolectomy for
massive perinatal embolism after emergency cesarean section. Ann Vasc Surg
61. British Committee for Standards in Haematology Writing Group, Baglin
TP, Brush J, Streiff M. Guidelines on use of vena cava filters. Br J Haematol
62. Harris SA, Velineni R, Davies AH. Inferior vena cava filters in pregnancy: a
systematic review. J Vasc Interv Radiol 2016;27:354–360.
63. Pabinger I, Grafenhofer H, Kyrle PA, et al. Temporary increase in the risk for
recurrence during pregnancy in women with a history of venous thromboembolism. Blood 2002;100:1060– 2.
64. Pabinger I, Grafenhofer H, Kaider A, et al. Risk of pregnancy-associated recurrent venous thromboembolism in women with a history of venous thrombosis.
J Thromb Haemost 2005;3:949–54.
65. Brill-Edwards P, Ginsberg JS, Gent M, et al. Safety of withholding heparin in
pregnant women with a history of venous thromboembolism. Recurrence of
Clot in This Pregnancy Study Group. N Engl J Med 2000;343:1439–44.
66. De Stefano V, Martinelli I, Rossi E, et al. The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis.
Br J Haematol 2006;135:386–91.
67. De Stefano V, Martinelli I, Rossi E, et al. The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis.
Br J Haematol 2006;135:386–91.
68. Lim W, Eikelboom JW, Ginsberg JS. Inherited thrombophilia and pregnancy
associated venous thromboembolism. BMJ 2007;334:1318–21.
69. Tormene D, Simioni P, Prandoni P, et al. Factor V Leiden mutation and
the risk of venous thromboembolism in pregnant women. Haematologica
70. Baglin T, Gray E, Greaves M, et al. Clinical guidelines for testing for heritable
thrombophilia. Br J Haematol 2010;149:209–20.
71. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on
an update of the classification criteria for definite antiphospholipid syndrome
(APS). J Thromb Haemost 2006;4:295–306.
72. Pengo V, Tripodi A, Reber G, et al. Update of the guidelines for lupus anticoagulant detection. J Thromb Haemost 2009;7:1737–40.
73. Robertson L, Wu O, Langhorne P, et al. Thrombophilia in pregnancy: a systematic review. Br J Haematol 2006;132:171–96.
74. American College of Obstetricians and Gynecologists Women’s Health Care
Physicians. ACOG Practice Bulletin No. 138: Inherited thrombophilias in
pregnancy. Obstet Gynecol 2013;122:706–17.
75. Mak A, Cheung MW, Cheak AA, Ho RC. Combination of heparin and aspirin is
superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression. Rheumatology (Oxf) 2010;49:281–8.
76. Laskin CA, Spitzer KA, Clark CA, et al. Low molecular weight heparin and
aspirin for recurrent pregnancy loss: results from the randomized, controlled
HepASA Trial. J Rheumatol 2009;36:279–87.
77. Farquharson RG, Quenby S, Greaves M. Antiphospholipid syndrome in
pregnancy: a randomized, controlled trial of treatment. Obstet Gynecol
78. Bates SM, Jaeschke R, Stevens SM, et al. Diagnosis of DVT: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians
Evidence-Based Clinical Practice Guidelines. Chest 2012;141( 2 Suppl):e351S–
79. Lubbe WF, Butler WS, Palmer SJ, Liggins GC. Fetal survival after prednisone
suppression of maternal lupus-anticoagulant. Lancet 1983; 1(8338):1361–3.
80. Lockshin MD, Druzin ML, Qamar T. Prednisone does not prevent recurrent
fetal death in women with antiphospholipid antibody. Am J Obstet Gynecol
81. Silver RK, MacGregor SN, Sholl JS, et al. Comparative trial of prednisone
plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients. Am J Obstet Gynecol 1993;169:1411–7.
82. Cowchock FS, Reece EA, Balaban D, et al. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial
comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol
83. Laskin CA, Bombardier C, Hannah ME, et al. Prednisone and aspirin in
women with autoantibodies and unexplained recurrent fetal loss. N Engl J
84. Dendrinos S, Sakkas E, Makrakis E. Low-molecular-weight heparin versus
intravenous immunoglobulin for recurrent abortion associated with antiphospholipid antibody syndrome. Int J Gynaecol Obstet 2009;104:223–5.
85. Cohen H, Arachchillage DRJ, Beyer-Westendorf J, et al. Direct oral anticoagulants and women. Semin Thromb Hemost 2016;42:789–97.
86. Bates SM, Middeldorp S, Rodger M, et al. Guidance for the treatment and
prevention of obstetric-associated venous thromboembolism. J Thromb
87. Knol HM, Schultinge L, Veeger NJ, et al. The risk of postpartum hemorrhage
in women using high dose of low-molecular-weight heparins during pregnancy. Thromb Res 2012;130:334–8.
88. Barbour LA, Smith JM, Marlar RA. Heparin levels to guide thromboembolism
prophylaxis during pregnancy. Am J Obstet Gynecol 1995;173:1869–73.
89. Bergqvist A, Bergqvist D, Lindhagen A, Mätzsch T. Late symptoms after pregnancy-related deep vein thrombosis. Br J Obstet Gynaecol 1990;97:338–41.
90. Rodger M. Evidence base for the management of venous thromboembolism in
pregnancy. Hematology Am Soc Hematol Educ Program. 2010;2010:173–80.
91. Bleker SM, Buchmüller A, Chauleur C, et al. Low-molecular-weight heparin to
prevent recurrent venous thromboembolism in pregnancy: Rationale and design
of the Highlow study, a randomised trial of two doses. Thromb Res 2016;144:62–8.
92. Horlocker TT, Wedel DJ, Rowlingson JC, et al. Regional anesthesia in the
patient receiving antithrombotic or thrombolytic therapy: American Society
of Regional Anesthesia and Pain Medicine evidence-based guidelines (third
edition). Reg Anesth Pain Med 2010;35:64–101.
93. Lapostolle F, Surget V, Borron SW, et al. Severe pulmonary embolism associated with air travel. N Engl J Med 2001;345:779–83.
94. Lapostolle F, Le Toumelin P, Chassery C, et al. Gender as a risk factor for pulmonary embolism after air travel. Thromb Haemost 2009;102:1165–8.
95. Cannegieter SC, Rosendaal FR. Pregnancy and travel-related thromboembolism. Thromb Res 2013;131 Suppl 1:S55–58.
96. Miller GJ, Bauer KA, Cooper JA, Rosenberg RD. Activation of the coagulant
pathway in cigarette smokers. Thromb Haemost 1998;79:549–53.
97. Golomb BA, Chan VT, Denenberg JO, et al. Risk marker associations with venous thrombotic events: a cross-sectional analysis. BMJ Open 2014;4:e003208.
98. Lindqvist P, Dahlbäck B, Marŝál K. Thrombotic risk during pregnancy: a population study. Obstet Gynecol 1999;94:595–9.
99. Black M, Bhattacharya S, Fairley T, et al. Outcomes of pregnancy in women
using illegal drugs and in women who smoke cigarettes. Acta Obstet Gynecol
100. Mendelsohn C, Gould GS, Oncken C. Management of smoking in pregnant
women. Aust Fam Physician 2014;43:46–51.
101. Chamberlain C, O’Mara-Eves A, Oliver S, et al. Psychosocial interventions for
supporting women to stop smoking in pregnancy. Cochrane Database Syst Rev